InflaRx N.V. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals, Inc. |
$1.79 | $157.41 M | -2.5 | 51 | $0 |
CCCC
C4 Therapeutics, Inc. |
$3.87 | $320.64 M | -1.97 | 145 | $20.76 M |
DSGN
Design Therapeutics, Inc. |
$6.35 | $217.51 M | -3.7 | 54 | $0 |
ELDN
Eledon Pharmaceuticals, Inc. |
$4.27 | $107.05 M | -2.26 | 20 | $0 |
ERAS
Erasca, Inc. |
$2.57 | $647.94 M | -2.83 | 126 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$29.62 | $1.65 B | -11.47 | 108 | $0 |
EYPT
EyePoint Pharmaceuticals, Inc. |
$7.33 | $473.97 M | -5.03 | 121 | $46.02 M |
FULC
Fulcrum Therapeutics, Inc. |
$4.55 | $515.25 M | -5.15 | 76 | $2.81 M |
GBIO
Generation Bio Co. |
$1.07 | $216.88 M | -1.28 | 174 | $5.90 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$7.05 | $243.38 M | -1.59 | 133 | $0 |
GRTX
Galera Therapeutics, Inc. |
$0.03 | $5.93 M | -0.12 | 7 | $0 |
HOWL
Werewolf Therapeutics, Inc. |
$1.54 | $151.66 M | -3.17 | 45 | $19.94 M |
ICVX
Icosavax, Inc. |
$15.31 | $769.04 M | -6.96 | 60 | $582,000 |
IKNA
Ikena Oncology, Inc. |
$1.53 | $84.45 M | -1.11 | 14 | $9.16 M |
INZY
Inozyme Pharma, Inc. |
$2.93 | $286.39 M | -3.43 | 59 | $0 |
KRON
Kronos Bio, Inc. |
$0.95 | $44.62 M | -0.37 | 58 | $6.29 M |
KZR
Kezar Life Sciences, Inc. |
$6.56 | $49.85 M | -0.49 | 58 | $7.00 M |
OCUP
Ocuphire Pharma, Inc. |
$1.17 | $43.81 M | -3.6 | 14 | $19.05 M |
PASG
Passage Bio, Inc. |
$0.65 | $73.04 M | -0.77 | 58 | $0 |
PLX
Protalix BioTherapeutics, Inc. |
$1.77 | $82.11 M | 14 | 208 | $65.49 M |
RVPH
Reviva Pharmaceuticals Holdings, Inc. |
$1.78 | $42.94 M | -0.91 | 15 | $0 |
SLS
SELLAS Life Sciences Group, Inc. |
$0.93 | $83.74 M | -1.34 | 16 | $0 |
STOK
Stoke Therapeutics, Inc. |
$11.32 | $774.50 M | -6.14 | 110 | $8.78 M |